$ASPI

ASP Isotopes Inc.

ASP Isotopes develops isotope-enrichment technologies and produces specialized isotopes for customers in areas including pharmaceuticals, agrochemicals, nuclear medicine, semiconductors and nuclear energy. Its technologies include the Aerodynamic Separation Process and Quantum Enrichment. The company has three operating segments: Nuclear Fuels, focused on advanced nuclear fuels such as HALEU and Lithium-6; Specialist Isotopes and Related Services, focused on isotopes such as Carbon-14, Silicon-28 and Ytterbium-176 and related services; and Construction Services, which provides public civil engineering work, including road and drainage projects, in Hong Kong. ASP Isotopes also owns PET Labs, which produces fluorinated radioisotopes and active pharmaceutical ingredients, and Renergen, which produces LNG and liquid helium from natural gas in South Africa. Its revenue sources include isotope-related services, construction work, and sales of natural gas products. It also licenses enrichment technologies to QLE in exchange for a royalty on future QLE revenues. ASP Isotopes is headquartered in Dallas, Texas.

0
1
0

No SEC Form 4 filings for $ASPI in the last 30 days.

See all $ASPI insider activity →
Low

ASP Isotopes 3Q 2026: Revenue $5.12M, EPS ($0.21) — 10-Q Summary

ASP Isotopes reported 3Q 2026 revenue of $5.12M, up 303% YoY, driven by radiopharmacy sales and new LNG revenue. However, net loss widened to $30.37M, with higher operating and interest expenses. Gross profit improved, but helium and LNG segment recorded a $0.8M loss. Isotope shipments are planned for 2026-2027, with LNG margins expected to improve in 2027.

ASP Isotopes (ASPI) Starts Liquid Helium Deliveries Through South Africa Project

ASP Isotopes (ASPI) announced that its partner Tetra4, a subsidiary of Renergen, has begun stable liquid helium production in South Africa. Initial deliveries under existing offtake agreements have started, linking ASP Isotopes to commercial volumes. The company operates in the chemicals industry and is involved in the Virginia Gas Project, with a fair value estimate of $13.00. Production targets include 2,500 GJ/day of LNG and 70 Mcf/day of liquid helium.

ASPI sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 1 news story mentioning ASPI (ASP Isotopes Inc.). Coverage has been balanced: 0 bullish, 1 neutral, and 0 bearish.

Recent ASPI coverage spans financial news, mergers & acquisitions and corporate actions.

What's driving ASPI

  • Results show strong top-line growth from radiopharmacy and new LNG revenue, but losses widened due to higher operating and interest expenses.

    tradingview.com · Nov 16, 2026

  • First helium deliveries could validate the Virginia Gas catalyst and support future revenue expectations.

    finance.yahoo.com · Nov 6, 2026

  • The commissioning milestone removes operational uncertainty and signals future revenue from helium sales.

    seekingalpha.com · Oct 26, 2026

  • The new helium supply source could alleviate market tightness and boost ASP Isotopes' revenue outlook.

    SEC EDGAR 8-K · Oct 26, 2026

  • The joint venture creates a new commercial‑scale HALEU production capability, potentially boosting ASP Isotopes' long‑term revenue and positioning in advanced nuclear fuel markets.

    tradingview.com · Oct 15, 2026

AlphAI scores every news story that mentions ASPI with an AI model for sentiment and relevance, and aggregates insider trades from ASP Isotopes Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $ASPI

Score

ASP Isotopes 3Q 2026: Revenue $5.12M, EPS ($0.21) — 10-Q Summary

ASP Isotopes reported 3Q 2026 revenue of $5.12M, up 303% YoY, driven by radiopharmacy sales and new LNG revenue. However, net loss widened to $30.37M, with higher operating and interest expenses. Gross profit improved, but helium and LNG segment recorded a $0.8M loss. Isotope shipments are planned for 2026-2027, with LNG margins expected to improve in 2027.

ASP Isotopes (ASPI) Starts Liquid Helium Deliveries Through South Africa Project

ASP Isotopes (ASPI) announced that its partner Tetra4, a subsidiary of Renergen, has begun stable liquid helium production in South Africa. Initial deliveries under existing offtake agreements have started, linking ASP Isotopes to commercial volumes. The company operates in the chemicals industry and is involved in the Virginia Gas Project, with a fair value estimate of $13.00. Production targets include 2,500 GJ/day of LNG and 70 Mcf/day of liquid helium.

ASP Isotopes Inc. Announces that Renergen Limited’s Virginia Gas Project has Achieved Stable Liquid Helium Production

ASP Isotopes Inc. (ASPI) filed an SEC Form 8-K — Regulation FD Disclosure. EXHIBIT 99.1 ASP Isotopes Inc. Announces that Renergen Limited’s Virginia Gas Project has Achieved Stable Liquid Helium Production Phase 1 plant now in stable operation following commissioning; first liquid helium in storage ahead of initial deliveries to contracted offtakers DAL

$ASPIHighM&A· acquirer · announced

ASP Isotopes Inc. (ASPI): Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa

ASP Isotopes Inc. (ASPI) filed an SEC Form 8-K — Regulation FD Disclosure. EXHIBIT 99.1 Quantum Leap Energy and Necsa Sign Binding Heads of Agreement to Establish Joint Venture for HALEU Production in South Africa Joint Venture Supported by Offtake Agreements with TerraPower, Initial Regulatory Approvals, and Access to Site Infrastructure to enable QLE

$ASPIMedM&A· acquirer · definitive

ASP Isotopes Inc., a Delaware corporation, entered into an Agreement and Plan of Merger, by and among ENDRA Life Sciences Inc., a Delaware corporation, Noble…

ASP Isotopes Inc. (ASPI) filed an SEC Form 8-K — Regulation FD Disclosure. Item 7.01 . Regulation FD Disclosure. As previously disclosed, on June 25, 2026, ASP Isotopes Inc., a Delaware corporation (“ASPI” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”), by and among ENDRA Life Sciences Inc., a Delaware corporati

$ASPIMedDebt financing· 230.53M ZAR

ASP Isotopes Inc. (ASPI): Entry into a Material Definitive Agreement

ASP Isotopes Inc. (ASPI) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. On August 14, 2026, Renergen Limited (the “Borrower”), a wholly-owned subsidiary of ASP Isotopes Inc. (the “Company”), entered into a Second Amendment and Restatement Agreement (the “Second Amendment”) with The Standard Bank o

ASP Isotopes at emerging growth conference: push to commercialize key materials

ASP Isotopes (ASPI) presented at the Emerging Growth Conference, outlining plans to commercialize projects in helium, isotopes, and nuclear fuel. CEO Paul Mann highlighted execution risks and supply shortages. The stock is down 73% from its 52-week high. The company aims to generate revenue and free cash flow over the next six months, with Phase 2 of its South African helium and LNG project fully funded. PET Labs reported 50% revenue growth in H1 2024, with expectations to double in 2026. The co

Related tickers